SCHEMBL7701864

SCHEMBL7701864

CCCC(C)C(=O)Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 11/20 0.54
KDR P35968 4/20 0.53
CDK1 P06493 1/20 0.50
CDK2 P24941 1/20 0.50
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 1/20 0.43
KIT P10721 1/20 0.42
FLT1 P17948 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698302 0.92 CHEK1 (0.56) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7091922 0.89 CHEK1 (0.55) CHEK1KDRHSD17B10
SCHEMBL7704724 0.88 CHEK1 (0.60) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7697800 0.87 CHEK1 (0.57) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7701530 0.83 CHEK1 (0.57) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7000769 0.82 CHEK1 (0.64) CHEK1KDRCDK1CDK2NPC1
Hydrochloric Acid SCHEMBL7089690 0.81 CHEK1 (0.62) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7705309 0.81 KDR (0.69) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7814577 0.81 CHEK1 (0.57) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7094246 0.80 CHEK1 (0.54) CHEK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed